EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs

Angela Sang, Selena Zhuo, Adara Bochanis, José E Manautou, Raman Bahal, Xiao-Bo Zhong, Theodore P Rasmussen

BioDrugs · 2024-07 · 38 (4) · 511-526

DOI: 10.1007/s40259-024-00665-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioDrugs, online erschienen am 25.06.2024. Verfasst von Angela Sang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA. Hauptthemen laut MEDLINE: Oligonucleotides, Antisense, United States Food and Drug Administration, Drug Approval. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oligonucleotides, AntisenseUnited States Food and Drug AdministrationDrug ApprovalHumansUnited StatesRNA, MessengerAnimalsRNA Splicing

Substanzen

Oligonucleotides, AntisenseRNA, Messenger

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.
  • Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA. theodore.rasmussen@uconn.edu.
  • Institute for Systems Genomics, University of Connecticut, Storrs, CT, USA. theodore.rasmussen@uconn.edu.
  • Department of Molecular and Cell Biology, University of Connecticut, Storrs, CT, USA. theodore.rasmussen@uconn.edu.

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Sang, A., Zhuo, S., Bochanis, A., Manautou, J. E., Bahal, R., Zhong, X. B., & Rasmussen, T. P. (2024). Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs. BioDrugs, 38(4), 511-526. https://doi.org/10.1007/s40259-024-00665-2

Vancouver

Sang A, Zhuo S, Bochanis A, Manautou JE, Bahal R, Zhong XB, et al. Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs. BioDrugs. 2024;38(4):511-526. doi:10.1007/s40259-024-00665-2

BibTeX
@article{Sang2024,
  author = {Sang, Angela and Zhuo, Selena and Bochanis, Adara and Manautou, José E and Bahal, Raman and Zhong, Xiao-Bo and Rasmussen, Theodore P},
  title = {Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs},
  journal = {BioDrugs},
  year = {2024},
  volume = {38},
  number = {4},
  pages = {511--526},
  doi = {10.1007/s40259-024-00665-2}
}
Kostenlos starten →